Children Pain and Fever Reliever

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with the common cold, flu, headache, sore throat, and toothache. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The appropriate dosage of this product should be determined based on the patient's weight or age, as outlined in the dosage chart below. It is imperative that healthcare professionals do not exceed the recommended dosage, and they should be aware of the overdose warning associated with this product.

For administration, the tablet must be chewed completely and not swallowed whole. Dosing may be repeated every 4 hours as needed while symptoms persist, with a maximum of 5 doses within a 24-hour period.

Dosage Chart:

Weight (lbs)

• Under 24: Consult a doctor

• 24-35: 1 tablet

• 36-47: 1 ½ tablets

• 48-59: 2 tablets

• 60-71: 2 ½ tablets

• 72-95: 3 tablets

Age (yr)

• Under 2 years: Consult a doctor

• 2-3 years: 1 tablet

• 4-5 years: 1 ½ tablets

• 6-8 years: 2 tablets

• 9-10 years: 2 ½ tablets

• 11 years: 3 tablets

Dosing should be adjusted as directed by a healthcare professional.

Contraindications

Use of this product is contraindicated in the following situations:

Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, is prohibited due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

Additionally, this product should not be used in patients with a known allergy to acetaminophen or any of the inactive ingredients contained in this formulation, as this may lead to severe allergic reactions.

Warnings and Precautions

Severe liver damage may occur in children taking this product, which contains acetaminophen, if they exceed the maximum daily amount of 5 doses within a 24-hour period or if they are concurrently using other medications that also contain acetaminophen. Healthcare professionals should monitor for signs of liver impairment in patients using this medication.

Acetaminophen has been associated with severe skin reactions. Symptoms may include skin reddening, blistering, and rash. If any of these symptoms occur, it is imperative to discontinue use immediately and seek medical assistance.

In cases of severe sore throat that persists for more than 2 days or is accompanied by fever, headache, rash, nausea, or vomiting, it is essential to consult a physician promptly. This may indicate a more serious underlying condition that requires further evaluation.

Prior to administering this product, healthcare providers should inquire about any existing liver disease in the patient. Additionally, it is advisable to consult a doctor or pharmacist if the child is currently taking warfarin, a blood-thinning medication, due to potential interactions.

When using this product, it is critical not to exceed the recommended dosage. If pain worsens or persists beyond 5 days, or if fever intensifies or lasts more than 3 days, medical advice should be sought. New symptoms, as well as any redness or swelling, warrant immediate consultation with a healthcare professional, as these may indicate a serious condition.

In the event of an overdose, it is crucial to obtain medical help or contact a Poison Control Center immediately at 1-800-222-1222. Prompt medical attention is vital, even if no signs or symptoms are initially apparent.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions.

Severe liver damage may occur if the maximum daily amount of acetaminophen, which is more than 5 doses in 24 hours, is exceeded, or if it is taken concurrently with other medications containing acetaminophen. Patients should also be alerted to the risk of severe skin reactions associated with acetaminophen, which may manifest as skin reddening, blistering, or rash. In the event of any skin reaction, it is imperative to discontinue use and seek medical assistance immediately.

Additionally, if a patient experiences a sore throat that is severe, persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting, they should consult a healthcare professional promptly.

Patients are advised against using this product in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription. It is also contraindicated in individuals with a known allergy to acetaminophen or any of the inactive ingredients in the formulation.

Before using this product, patients should consult a doctor if they have liver disease or are taking the blood-thinning medication warfarin.

While using this product, it is crucial not to exceed the recommended dosage. Patients should discontinue use and seek medical advice if pain worsens or lasts more than 5 days, if fever worsens or lasts more than 3 days, if new symptoms arise, or if redness or swelling occurs, as these may indicate a serious condition.

In case of overdose, immediate medical help should be sought, or the Poison Control Center should be contacted at 1-800-222-1222. Quick medical attention is critical, even if no signs or symptoms are apparent.

This product should be kept out of reach of children to prevent accidental ingestion.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking warfarin, a blood-thinning agent. The combination may elevate the risk of bleeding, necessitating careful monitoring and potential dosage adjustments of either medication.

No additional drug interactions or laboratory test interactions have been identified for this medication.

Packaging & NDC

Below are the non-prescription pack sizes of Children Pain and Fever Reliever (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 to 11 years may be treated with this medication, with specific dosing based on weight. For children weighing under 24 lbs, consultation with a doctor is advised prior to use.

The recommended dosages are as follows:

• For children weighing 24-35 lbs (ages 2-3 years): 1 tablet.

• For children weighing 36-47 lbs (ages 4-5 years): 1 ½ tablets.

• For children weighing 48-59 lbs (ages 6-8 years): 2 tablets.

• For children weighing 60-71 lbs (ages 9-10 years): 2 ½ tablets.

• For children weighing 72-95 lbs (ages 11 years): 3 tablets.

It is important not to exceed 5 doses within a 24-hour period and to adhere strictly to the directed dosage to avoid overdose.

Healthcare professionals should advise parents to consult a doctor if the child has liver disease or is taking the anticoagulant warfarin. Additionally, parents should be instructed to discontinue use and seek medical advice if the child's pain worsens or persists beyond 5 days, if fever worsens or lasts more than 3 days, if new symptoms arise, or if there is any redness or swelling.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication. The prescribing information does not provide any recommended age considerations, dosage adjustments, safety concerns, or special precautions for this population. Therefore, healthcare providers should exercise clinical judgment when prescribing this medication to geriatric patients, considering individual patient factors and potential comorbidities. Monitoring for efficacy and safety is advised, as the absence of specific data does not preclude the need for careful assessment in elderly individuals.

Pregnancy

The prescribing information does not provide specific data regarding the use of acetaminophen during pregnancy, including safety concerns, dosage modifications, or special precautions. Therefore, healthcare professionals should exercise caution when recommending acetaminophen to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be informed of the lack of specific guidance and encouraged to consult their healthcare provider for personalized recommendations.

Lactation

There is no specific information available regarding the use of this product in lactating mothers. Additionally, there is no data on the potential for excretion in breast milk or any precautions that should be taken for breastfeeding women. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this product.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment should be closely monitored when using this product, as it contains acetaminophen, which is associated with the risk of severe liver damage. It is critical that patients do not exceed five doses within a 24-hour period, as this represents the maximum daily amount. Additionally, patients should avoid concomitant use with other medications containing acetaminophen to prevent the risk of overdose and subsequent liver injury.

Before initiating treatment, it is advisable for patients with liver disease to consult a healthcare professional. This precaution is essential to ensure the safe use of the product and to evaluate the potential need for dosage adjustments or alternative therapies based on the severity of hepatic impairment. Regular monitoring of liver function may be warranted in these patients to detect any signs of liver damage early.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222. Prompt medical intervention is crucial, even in the absence of noticeable signs or symptoms.

Healthcare professionals should be aware that the severity of symptoms may vary depending on the specific substance involved in the overdose. Therefore, a thorough assessment and monitoring of the patient are essential.

Management of an overdose may include supportive care and symptomatic treatment, tailored to the individual’s clinical presentation. Continuous evaluation and appropriate interventions should be initiated as necessary to mitigate potential complications associated with the overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

Postmarketing experience has identified rare cases of severe skin reactions associated with acetaminophen use. Reported symptoms include skin reddening, blistering, and rash. These events were documented through voluntary reports and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 in the event of an overdose, emphasizing that prompt medical attention is crucial even if no signs or symptoms are apparent.

Patients should be informed not to use this product in conjunction with any other medications that contain acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in other medications, patients are encouraged to consult with a doctor or pharmacist.

It is important to instruct patients not to use this product if their child has a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation.

Patients should be advised to discontinue use and consult a doctor if pain worsens or persists for more than 5 days, or if fever worsens or lasts longer than 3 days. Additionally, they should be informed to seek medical advice if new symptoms arise or if there is any redness or swelling, as these may indicate a serious condition.

When using this product, patients must be cautioned against exceeding the recommended dose, as this could lead to overdose.

Healthcare providers should also recommend that patients consult a doctor before use if their child has liver disease. Furthermore, it is advisable for patients to speak with a doctor or pharmacist prior to use if their child is currently taking the blood-thinning medication warfarin.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for reference. It should be stored at room temperature, ensuring that it is kept away from high humidity and protected from light exposure. For optimal preservation, it is essential to check the end flap of the packaging for the expiration date and lot number.

Additional Clinical Information

The medication is administered orally, with a recommended repeat dose every 4 hours as long as symptoms persist. Clinicians should ensure that patients do not exceed 5 doses within a 24-hour period. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Children Pain and Fever Reliever, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)